MODIFICATION
A -- Smallpox Antiviral
- Notice Date
- 9/9/2022 2:16:20 PM
- Notice Type
- Justification
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- ASPR BARDA DIV CONTRACTS MGMT & ACQ Washington DC 20515 USA
- ZIP Code
- 20515
- Solicitation Number
- 75A50122C00047
- Archive Date
- 10/09/2022
- Point of Contact
- Kevin Dean, Jill Johnson, Contracting Officer
- E-Mail Address
-
Kevin.dean1@hhs.gov, jill.johnson@hhs.gov
(Kevin.dean1@hhs.gov, jill.johnson@hhs.gov)
- Award Number
- 75A50122C00047
- Award Date
- 08/26/2022
- Description
- The scope of work for this contract (across the Base and Option periods) includes the manufacture and delivery of up to 1.7 Million Treatment Courses (TCs) of the smallpox antiviral TEMBEXA, comprising oral tablets and oral suspension formulation to the SNS and the associated activities.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/f28dfd92867d480d855ac8de84b5303b/view)
- Record
- SN06458827-F 20220911/220909230125 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |